Cell Signal Pathway
LC Laboratories는 세포의 신호전달체계의 연구에 사용되는 다양한 Inhibitor와 activator를 제조 개발하는 회사입니다. Protein Tyrosine Kinase, PI3K/ERK/mTOR, JAK/STAT, Apoptosis, Autophagy, MAPK/ERK등의 세포신호전달 Pathway에 관련된 Small molecules에 대한 오랜 노하우와 꾸준한 연구를 거듭하여, 생물학적 그리고 약리학적 활성이 검증된 고품질, 고순도의 제품을 제공하고 있습니다.
Cat.No | Description |
---|---|
I-5577 | Imatinib, Free Base, >99% [CGP-57148B] [STI-571] |
I-5508 | Imatinib, Methanesulfonate Salt, >99% [STI-571] [CGP-57148B] |
A-1107 | Axitinib, Free Base, >99% |
L-5814 | Linsitinib, Free Base, >99% [OSI-906] [OSI 906AA] |
C-4300 | Cediranib, Free Base, >99% [AZD2171] |
D-3700 | Dacomitinib, Free Base, >99% [PF00299804] [PF299] [PF299804] |
L-5400 | Lenvatinib, Free Base, >99% [E7080] [ER20349200] |
A-2311 | Alectinib, Hydrochloride Salt, >99% [AF802] [CH5424802] |
L-4899 | Lapatinib, Free Base, >99% [GSK 572016] [GW-572016] |
L-4804 | Lapatinib, Di-p-Toluenesulfonate Salt, >99% [GSK 572016] |
A-2300 | Alectinib, Free Base, >99% |
G-5903 | GW2580, Free Base, >99% |
C-2086 | Ceritinib, Free Base, >99% [LDK-378] |
M-7007 | Masitinib, Free Base, >99% [AB-1010] |
R-8024 | Regorafenib, Free Base, >99% [Bay 73-4506] [Fluoro-Sorafenib] |
C-8901 | Cabozantinib, Free Base, >99% [BMS-907351] [XL-184] |
C-8999 | Cabozantinib, S-Malate Salt, >99% [XL-184] |
N-6404 | Neratinib, Free Base, >99% [HKI-272] |
G-4408 | Gefitinib, Free Base, >99% [ZD-1839] |
A-8644 | Afatinib, Free Base, >99% |
N-9077 | Nintedanib, Free Base, >99% [BIBF1120] [Intedanib] [Vargatef] |
N-9055 | Nintedanib, Ethanesulfonate Salt, >99% [BIBF1120 Esylate] |
C-7900 | Crizotinib, Free Base, >99% [PF-02341066] [PF-1066] |
N-6404 | Neratinib, Free Base, >99% [HKI-272] |
G-6055 | Genistein, >99% |
E-4007 | Erlotinib, Hydrochloride Salt, >99% [CP-358774] |
E-4997 | Erlotinib, Free Base, >99% [CP-358774] [OSI-774] [Ro 50-8231] |
C-1201 | Canertinib, Dihydrochloride Salt, >99% |
S-8877 | Sunitinib, Free Base, >99% [PHA-290940AD] [PNU-290940AD] |
S-8803 | Sunitinib, Malate Salt, >99% [PHA-290940AD] |
V-9402 | Vandetanib, Free Base, >99% [ZD6474] |
O-7200 | Osimertinib, Free Base, >99% [AZD9291] [Mereletinib] |
O-7233 | Osimertinib, Methanesulfonate Salt, >99% [AZD9291] |
P-6706 | Pazopanib, Free Base, >99% [GW-786034] |
P-6755 | Pazopanib, Hydrochloride Salt, >99% [GW-786034] |
Cat.No | Description |
---|---|
D-6660 | Daunorubicin, Hydrochloride Salt, >98% |
G-7322 | GW590735, Free Acid, >99% |
I-4122 | Irinotecan, Hydrochloride Salt, Trihydrate, >99% |
O-9201 | Olaparib, >99% [AZD-2281] [KU-59436] |
D-4000 | Doxorubicin, Hydrochloride Salt, >99% [FI-106] |
N-5665 | Niraparib, Free Base, >99% [MK-4827] |
N-5688 | Niraparib, p-Toluenesulfonate Salt, >99% [MK-4827] |
O-7111 | Oxaliplatin, >99% [RP 54780] |
C-2799 | Capecitabine, >99% [Capecitabin] [Ro 09-1978] |
R-6300 | Rucaparib, Free Base, >99% |
R-6399 | Rucaparib, Phosphate Salt, >99% [AG-14699] [AG014699] |
G-1111 | GW7647, Free Acid, >99% |
G-4199 | Gemcitabine, Free Base, >99% [dFdC] [dFdCyd] [LY-188011] |
G-4177 | Gemcitabine, Hydrochloride Salt, >99% [dFdC] [dFdCyd] |
E-8000 | Epirubicin, Hydrochloride Salt, >99% [4'-Epidoxorubicin] |
V-4703 | Veliparib, Free Base, >99%V-4703 |
Cat.No | Description |
---|---|
F-9929 | Forskolin, >99% [Colforsin] |
S-4699 | Sonidegib, Diphosphate Salt, >99% [Erismodegib Diphosphate] |
S-4680 | Sonidegib, Free Base, >99%[Erismodegib] [LDE225] |
Cat.No | Description |
---|---|
E-4506 | Enzastaurin, Free Base, >99% |
S-9300 | Staurosporine, Free Base, >99% [Antibiotic AM-2282] |
Cat.No | Description |
---|---|
S-4490 | Selumetinib, Free Base, >99% [AZD6244] [ARRY-142886] |
D-2744 | Doramapimod, Free Base, >99% [BIRB 796] |
P-8900 | PLX4720, Free Base, >99% |
S-8599 | Sorafenib, Free Base, >99% [Bay 43-9006] |
S-8502 | Sorafenib, p-Toluenesulfonate Salt, >99% |
V-2800 | Vemurafenib, Free Base, >99% [PLX4032] [R7204] [RG7204] |
P-9688 | PD 325901, Free Base, >99% [MEK1/2 Inhibitor III] [PD0325901] |
P-4313 | PD 98059, >99% |
C-1100 | Cobimetinib, Free Base, >99% [GDC0973] [RG7420] [XL518] |
S-1700 | SB 202190, Free Base, >99% [FHPI] |
S-3400 | SB 203580, Free Base, >99% |
D-5678 | Dabrafenib, Free Base, >99% [GSK-2118436] [GSK-2118436A] |
D-5699 | Dabrafenib, Methanesulfonate Salt, >99% [GSK-2118436] |
S-7979 | SP600125, >99% [JNK Inhibitor II] [SAPK Inhibitor II] |
T-8123 | Trametinib, >99% [GSK-1120212] [JTP-74057] |
T-8188 | Trametinib, DMSO Solvate, >99% [JTP-74057] [Trametinib] |
U-6770 | U0126, >99% |
B-2332 | Binimetinib, Free Base, >99% [ARRY438162] [ARRY-162] [MEK162] |
Cat.No | Description |
---|---|
F-4660 | Fasudil, Monohydrochloride Salt, >99% [AT-877] [HA-1077] |
P-7744 | Palbociclib, Free Base, >99% [PD332991] |
P-7788 | Palbociclib, Hydrochloride Salt, >99% [PD332991] |
P-7766 | Palbociclib, Isethionate Salt, >99% [PD332991] |
R-8200 | Ribociclib, Free Base, >99% [Lee011] |
T-9753 | Thiazovivin, Free Base, >99% [Tzv] |
Y-5301 | Y-27632, Dihydrochloride Salt, >99% [Y27] |
R-1234 | Roscovitine, Free Base, >99% [CYC202] |
Cat.No | Description |
---|---|
F-4077 | Fenretinide, >99% [4-HPR] [MK-4016] [McN-R-1967] |
N-3883 | Nelfinavir, Methanesulfonate Salt, >99% [AG-1343] |
B-1408 | Bortezomib, Free Base, >99% [MG-341] [PS-341] |
C-3987 | Calyculin A, >98% |
D-5600 | Daporinad, Free Base, >99% [APO866] [FK866] [K22.175] [WK175] |
B-2422 | Bexarotene, Free Acid, >99% [LGD-1069] [LG 1069] [LG100069] |
C-3022 | Carfilzomib, Free Base, >99% [PR-171] |
D-2946 | Daidzein, >99% |
O-2220 | Okadaic Acid, Free Acid, >98% [Halochondrine A] |
O-5857 | Okadaic Acid, Sodium Salt, >98% [Halochondrine A] |
O-7519 | Okadaic Acid, Potassium Salt, >98% [Halochondrine A] |
O-6410 | Okadaic Acid, Ammonium Salt, >98% [Halochondrine A] |
E-2121 | Enasidenib, Free Base, >99% [AG221] |
B-1788 | Bosutinib, Free Base, >99% [SKI-606] |
Cat.No | Description |
---|---|
V-8477 | Vorinostat, >99% [MK-0683] [SAHA] |
P-3703 | Panobinostat, Free Base, >99% [LBH-589] [NVP-LBH-589] |
E-3866 | Entinostat, Free Base, >99% [Histone Deacetylase Inhibitor I] |
D-3899 | Decitabine, Free Base, >99% [5-Aza-2'-deoxycytidine] [5-Aza-dC |
Cat.No | Description |
---|---|
D-3307 | Dasatinib, Free Base, >99% [BMS-354825] |
B-9800 | Brigatinib, Free Base, >99% [AP26113] |
D-8147 | Duvelisib, Free Base, >99% [IPI-145] [INK-1197] |
C-6000 | Cyclosporin A, >99% [Antibiotic S 7481F1] [Ciclosporin A] [CsA] |
I-3311 | Ibrutinib, Free Base, >99% [CRA-032765] [PCI-32765] |
N-8207 | Nilotinib, Free Base, >99% [AMN-107] |
N-8266 | Nilotinib, Hydrochloride Salt, Monohydrate, >99% |
B-1788 | Bosutinib, Free Base, >99% [SKI-606] |
P-7022 | Ponatinib, Free Base, >99% [AP 24534] |
D-3699 | Dovitinib, Lactate Salt, >99% [CHIR-258] [TKI-258] |
D-3608 | Dovitinib, Free Base, >99% [CHIR-258] [TKI-258] |
I-1500 | Infigratinib, Free Base, >99% [BGJ398] [NVPBGJ398] |
Q-4747 | Quizartinib, Free Base, >99% [AC220] [AC010220] |
Cat.No | Description |
---|---|
H-5239 | H-89, Dihydrochloride Salt, >99% |
D-3197 | Dorsomorphin, Free Base, >99% [AMPK Inhibitor I] [BML-275] |
A-1098 | AICAR, Free Base, >99% |
W-2990 | Wortmannin, >99% [KY 12420] |
I-3344 | INK128, Free Base, >99% [MLN0128] [Sapanisertib] |
P-9099 | PI-103, Free Base, >99% [PI3-Kinase α Inhibitor I] |
A-4477 | Alpelisib, Free Base, >99% [BYL-719] [NVP-BYL719] |
L-7962 | LY 294002, Free Base, >99% |
R-5000 | Rapamycin, >99% [AY-22989] [LCP-Siro] [RAPA] [Sirolimus] |
E-4040 | Everolimus, >99% [RAD001] [SDZ-RAD] |
T-8040 | Temsirolimus, >99% [CCI-779] |
W-2990 | Wortmannin, >99% [KY 12420] |
A-2345 | AZD8055, Free Base, >99% |
D-3197 | Dorsomorphin, Free Base, >99% [AMPK Inhibitor I] [BML-275] |
C-6556 | CHIR99021, Free Base, >99% [CHIR 911] [CT99021] |
T-7887 | Torin 1, Free Base, >99% [mTOR Inhibitor XI] |
T-8448 | Torin 2, Free Base, >99% [mTOR Inhibitor XII] |
F-4900 | FK-506, >99% [FR-900506] |
A-1803 | A-769662, >99% |
I-7447 | Idelalisib, Free Base, >99% [CAL-101] [GS-1101] |
G-9252 | GDC-0941, Free Base, >99% [Pictilisib] |
Cat.No | Description |
---|---|
P-7177 | Pemetrexed, Disodium Salt, Heptahydrate, >99% |
S-9344 | Stauprimide, >99% [N-Benzoyl-7-oxostaurosporine] |
V-3579 | Venetoclax, Free Base, >99% [ABT-199] [GDC-0199] [RG7601] |
B-9135 | Birinapant, Free Base, >99% [TL-32711] |
Cat.No | Description |
---|---|
C-2581 | Cabazitaxel, >99% [RPR-116258] [Taxoid XRP6258] |
N-5300 | NVP-AUY922, >99% [AUY922] [Luminespib] [VER-52296] |
P-9600 | Paclitaxel, >99.5% |
V-7300 | Vinblastine, Sulfate Salt, >98% [29060-LE] [Nincaluicolflastine] |
D-1000 | Docetaxel, >99%[RP 56976] |
P-1010 | Phorbol, >99% |
P-1680 | Phorbol 12-Myristate 13-Acetate, >99.5% [Cocarcinogen A1] |
P-4833 | Phorbol 12,13-Dibutyrate, >99% [PDBu] |
P-7600 | PKC412, >99% [Midostaurin] [4'-N-Benzoyl Staurosporine] |
Cat.No | Description |
---|---|
L-6100 | Leptomycin B, Free Acid, >98% [ATS 1287B] [CI-940] [CL-1957A] |
B-8500 | Brefeldin A, >99% [Ascotoxin] [Cyanein] [Decumbin] |
Cat.No | Description |
---|---|
V-4050 | Vismodegib, Free Base, >99% [GDC-0449] [HhAntag691] |
C-8700 | Cyclopamine, Free Base, >99% [11-Deoxyjervine] |
Cat.No | Description |
---|---|
C-6000 | Cyclosporin A, >99% [Antibiotic S 7481F1] [Ciclosporin A] [CsA] |